UNSPSC 51422208: Flunarizine hydrochloride

This classification denotes a histamine-1 receptor antagonist and calcium channel blocker with the molecular formula C26H26F2N2.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C11102TO53, chemically known as (e)-1-(bis-(p-fluorophenyl)methyl)-4-cinnamylpiperazine dihydrochloride, but more generally known as flunarizine hydrochloride, which bears US NIH Compound Identifier 5282407.

UNSPSC 51422208 Flunarizine hydrochloride, a Commodity code, shows minimal recent state and local procurement activity aligned with its pharmaceutical scope. The single recent opportunity posted under this code—Seminole County, Florida's IFB 60459723LAS—solicits naloxone and safe drug deactivation systems rather than flunarizine hydrochloride, suggesting a classification mismatch between the code assignment and the actual procurement need. State and local health departments and county public health agencies would be the expected issuing bodies for pharmaceutical acquisitions under this commodity, though current activity does not clearly reflect this pattern.

Seminole County, Florida posted the only recent opportunity on June 30, 2026, with a response deadline of July 26, 2023 (note: the due date appears internally inconsistent in the source). The county sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford. Vendors were required to submit electronic bids including all shipping and delivery costs, maintain drug-free workplace certification and E-Verify compliance, and carry workers' compensation, commercial general liability, and professional liability insurance. The contract offered an initial two-year term with one-year renewal option. Because the opportunity description does not match the flunarizine hydrochloride commodity code, business development professionals should verify whether this code accurately captures pharmaceutical procurement in target jurisdictions or whether misclassification has obscured relevant activity.